Showing results (91-100 of 206) with videos related to
Sort By:
Pageof 21
Journal for Immunotherapy of Cancer|January 27, 2021
Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanomaRebecca Pokorny, Jordan P McPherson, Benjamin Haaland, et al.Journal of Kidney Cancer and VHL|August 5, 2024
Clinical, Genomic, and Transcriptomic Characteristics of Patients with Metastatic Renal Cell Carcinoma Who Developed Thromboembolic EventsGliceida Galarza Fortuna, Beverly Chigarira, Vinay Mathew Thomas, et al.Experimental Hematology|June 9, 2009
Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cuesHiroto Araki, Sudhakar Baluchamy, Kazumi Yoshinaga, et al.Cancers|April 3, 2021
Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor TherapyJohn M Rieth, Umang Swami, Sarah L Mott, et al.European Urology Focus|July 14, 2022
Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis-Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-Resistant Prostate Cancer SettingNicolas Sayegh, Nishita Tripathi, Roberto H Nussenzveig, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2025
Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate CancerChadi Hage Chehade, Ryon P Graf, Zeynep Irem Ozay, et al.Biomedicines|December 23, 2022
Detection of BRCA1, and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World SettingTaylor Ryan McFarland, Vinay Mathew Thomas, Roberto Nussenzveig, et al.Molecular Cancer Therapeutics|October 5, 2022
External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate CancerUmang Swami, Nicolas Sayegh, Yeonjung Jo, et al.Diagnostics (Basel, Switzerland)|September 14, 2024
Effectiveness of ChatGPT 4.0 in Telemedicine-Based Management of Metastatic Prostate CarcinomaEmre Dal, Ayana Srivastava, Beverly Chigarira, et al.Current Medical Research and Opinion|July 23, 2020
Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinomaArielle G Bensimon, Yichen Zhong, Umang Swami, et al.Pageof 21